F2R and cancer: Compared to the stringent control of PAR1 activation in normal tissues, PAR1 is constitutively overexpressed by cancer cells through activation of many downstream signaling cascades including the MMP1, signal transducer and activator of transcription 3 (STAT3), AKT, and VEGF pathways [6].